Federal Funding Opportunities, November 15-28, 2021

Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed) (PAR-22-073) National Cancer Institute National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke National Institute of Nursing Research National Institute for Occupational Safety and Health Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt Date(s): December 15, 2021; February 2, 2022; November 15, 2022; February 2, 2023; November 15, 2023; February 2, 2024 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) (RFA-AT-22-003) National Center for Complementary and Integrative Health National Center for Advancing Translational Sciences National Institute on Aging National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Dental and Craniofacial Research National Institute of Neurological Disorders and Stroke Office of Research on Women’s Health Application Receipt Date(s): February 11, 2022 NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional) (RFA-DA-22-036) National Institute on Drug Abuse National Institute on Aging National Institute of Mental Health Office of Behavioral and Social Sciences Research Office of Disease Prevention Application Receipt Date(s): March 02, 2022 Understanding Place-Based Health Inequalities in Mid-Life (R01 Clinical Trial Not Allowed) (RFA-AG-23-004) National Institute on Aging Application Receipt Date(s): March 03, 2022 Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required) (RFA-MH-22-150) National Institute of Mental Health Application Receipt Date(s): February 22, 2023 NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) (RFA-HL-23-009) National Heart, Lung, and Blood Institute Application Receipt Date(s): February 28, 2024 NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) (RFA-HL-23-008) National Heart, Lung, and Blood Institute National Center for Advancing Translational Sciences Application Receipt Date(s): February 28, 2024 Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 – Clinical Trial Optional) (PAR-21-353) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): November 05, 2024 Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 – Clinical Trial Optional) (PAR-21-354) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): November 16, 2024 Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 – Clinical Trial Optional) (PAR-21-355) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): November 16, 2024 Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) (PAR-22-072) National Institute on Minority Health and Health Disparities National Cancer Institute National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences National Institute of Mental Health Office of Behavioral and Social Sciences Research Office of Disease Prevention Application Receipt Date(s): Multiple dates, see announcement.